Roche inks deal with Diabeloop to integrate automated insulin delivery

"Swiss pharma company Roche’s insulin pump will be the next to support automated insulin delivery thanks to a partnership with French AI company Diabeloop.
As part of the deal, users will be able to integrate Roche’s Accu-Chek Insights insulin pump with the Diabeloop monitoring system. This integration will result in a hybrid closed-loop system – a system designed to take the pressure off the patient to dose glucose, instead relying on an algorithm for support.
Typically, hybrid systems are made up of a continuous glucose monitor (CGM), an insulin pump and a glucose-detecting algorithm.
The Diabeloop system uses and algorithm to continuously monitor insulin levels and data. It can then stop insulin delivery, adjust the basal rate or deliver automatic correction bolus. In a hybrid system like this the algorithm is largely able to calculate and adjust insulin delivery, except at meals when patients have to take control over the dosing.
The hybrid system will first be rolled out in Germany, Italy, Spain, Switzerland and the Netherlands in 2021..." Lire la suite